• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antiretrovirals and Risk of COVID-19 Diagnosis and Hospitalization in HIV-Positive Persons.

作者信息

Del Amo Julia, Polo Rosa, Moreno Santiago, Díaz Asunción, Martínez Esteban, Arribas José Ramón, Jarrín Inma, Hernán Miguel A

机构信息

National Plan against AIDS, Ministry of Health, Paseo del Prado 19, 28004 Madrid, Spain.

National Plan on AIDS, Ministry of Health, Madrid, Spain.

出版信息

Epidemiology. 2020 Nov;31(6):e49-e51. doi: 10.1097/EDE.0000000000001235.

DOI:10.1097/EDE.0000000000001235
PMID:32773469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7541717/
Abstract
摘要

相似文献

1
Antiretrovirals and Risk of COVID-19 Diagnosis and Hospitalization in HIV-Positive Persons.抗逆转录病毒药物与HIV阳性者新冠病毒诊断及住院风险
Epidemiology. 2020 Nov;31(6):e49-e51. doi: 10.1097/EDE.0000000000001235.
2
Persons living with HIV may be reluctant to access to COVID-19 testing services: data from 'D. Cotugno' Hospital, Naples, Southern Italy.
AIDS. 2020 Nov 15;34(14):2151-2152. doi: 10.1097/QAD.0000000000002678.
3
Late Diagnosis of COVID-19 in Patients Admitted to the Hospital.入院患者中新冠肺炎的延迟诊断
J Gen Intern Med. 2020 Sep;35(9):2829-2831. doi: 10.1007/s11606-020-05949-1. Epub 2020 Jun 15.
4
[A few hints to face Covid-19 pandemic in Italy].[应对意大利新冠疫情的几点提示]
Epidemiol Prev. 2020 Jul-Aug;44(4):201. doi: 10.19191/EP20.4.P201.049.
5
Screening maternity populations during the COVID-19 pandemic.在新冠疫情期间对孕产妇群体进行筛查。
BJOG. 2020 Nov;127(12):1557. doi: 10.1111/1471-0528.16439. Epub 2020 Sep 1.
6
Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory.为您的实验室选择一种SARS-CoV-2/新冠病毒分子检测方法。
J Appl Lab Med. 2020 Jul 1;5(4):837-840. doi: 10.1093/jalm/jfaa076.
7
Issues to be considered when planning sero-epidemiological studies in regions with a low incidence of SARS-CoV-2.在新冠病毒2型（SARS-CoV-2）低发病率地区规划血清流行病学研究时需考虑的问题。
Am J Infect Control. 2020 Sep;48(9):1127-1128. doi: 10.1016/j.ajic.2020.06.176. Epub 2020 Jun 17.
8
Testing for COVID-19.新型冠状病毒肺炎检测
Lancet Respir Med. 2020 Jul;8(7):e63-e64. doi: 10.1016/S2213-2600(20)30247-2. Epub 2020 May 29.
9
Are we underestimating seroprevalence of SARS-CoV-2?我们是否低估了新冠病毒的血清阳性率？
BMJ. 2020 Sep 3;370:m3364. doi: 10.1136/bmj.m3364.
10
Laboratory Diagnosis of COVID 19 - Perspectives.新型冠状病毒肺炎的实验室诊断——视角
J Assoc Physicians India. 2020 Jul;68(7):11-12.

引用本文的文献

1
Effect of Tenofovir Alafenamide Fumarate on the outcomes of hospitalized COVID-19 patients: a prospective, block-balanced, open-label, randomized controlled trial.富马酸替诺福韦艾拉酚胺对住院 COVID-19 患者结局的影响：一项前瞻性、区组平衡、开放标签、随机对照临床试验。
BMC Pharmacol Toxicol. 2024 Oct 17;25(1):78. doi: 10.1186/s40360-024-00781-3.
2
Clinical Outcomes of Coronavirus Disease 2019 in People Living With Human Immunodeficiency Virus in South Korea: A Nationwide Population-Based Cohort Study.韩国艾滋病毒感染者感染 2019 年冠状病毒病的临床结局：一项全国基于人群的队列研究。
Influenza Other Respir Viruses. 2024 Jun;18(6):e13337. doi: 10.1111/irv.13337.
3
Clinical outcomes and immunological response to SARS-CoV-2 infection among people living with HIV.HIV 感染者感染 SARS-CoV-2 的临床结局和免疫反应。
Exp Biol Med (Maywood). 2024 Apr 2;249:10059. doi: 10.3389/ebm.2024.10059. eCollection 2024.
4
Effects of entecavir and tenofovir disoproxil fumarate on the incidence and severity of COVID-19 in patients with chronic hepatitis B.恩替卡韦和富马酸替诺福韦二吡呋酯对慢性乙型肝炎患者 COVID-19 发病率和严重程度的影响。
BMC Infect Dis. 2023 Nov 30;23(1):843. doi: 10.1186/s12879-023-08838-0.
5
Tenofovir-Containing Antiretroviral Therapy and Clinical Outcomes of SARS-CoV-2 Infection in People Living with HIV.含替诺福韦的抗逆转录病毒治疗与 HIV 感染者感染 SARS-CoV-2 的临床结局。
Viruses. 2023 May 9;15(5):1127. doi: 10.3390/v15051127.
6
Drug Repurposing and Observational Studies: The Case of Antivirals for the Treatment of COVID-19.药物重定位和观察性研究：以抗病毒药物治疗 COVID-19 为例。
Ann Intern Med. 2023 Apr;176(4):556-560. doi: 10.7326/M22-3582. Epub 2023 Mar 28.
7
Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout.人类免疫缺陷病毒状况、替诺福韦暴露与新冠肺炎结局不良的风险：疫苗推出前来自 6 个美国队列的真实世界分析。
Clin Infect Dis. 2023 May 24;76(10):1727-1734. doi: 10.1093/cid/ciad084.
8
The clinical and epidemiological characteristics of a series of patients living with HIV admitted for COVID-19 in a district hospital.在一家地区医院因 COVID-19 住院的一系列 HIV 感染者的临床和流行病学特征。
BMC Infect Dis. 2023 Feb 28;23(1):123. doi: 10.1186/s12879-023-08004-6.
9
Clinical characteristics associated with mortality of COVID-19 patients admitted to an intensive care unit of a tertiary hospital in South Africa.南非一家三级医院 ICU 收治的 COVID-19 患者死亡相关的临床特征。
PLoS One. 2022 Dec 30;17(12):e0279565. doi: 10.1371/journal.pone.0279565. eCollection 2022.
10
Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers.每日替诺福韦二吡呋酯/恩曲他滨和羟氯喹用于 COVID-19 的暴露前预防：医护人员中一项双盲安慰剂对照随机试验。
Clin Microbiol Infect. 2023 Jan;29(1):85-93. doi: 10.1016/j.cmi.2022.07.006. Epub 2022 Aug 5.

本文引用的文献

1
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy : A Cohort Study.接受抗逆转录病毒疗法的 HIV 阳性者中 COVID-19 的发病率和严重程度：一项队列研究。
Ann Intern Med. 2020 Oct 6;173(7):536-541. doi: 10.7326/M20-3689. Epub 2020 Jun 26.
2
Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.抗 SARS-CoV-2 感染的 FDA 批准药物在雪貂中的抗病毒疗效。
mBio. 2020 May 22;11(3):e01114-20. doi: 10.1128/mBio.01114-20.
3
Lopinavir-ritonavir in severe COVID-19.洛匹那韦-利托那韦治疗重症新型冠状病毒肺炎
Nat Med. 2020 Apr;26(4):465. doi: 10.1038/s41591-020-0849-9.
4
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study.利巴韦林、瑞德西韦、索非布韦、加洛韦和替诺福韦对 SARS-CoV-2 RNA 依赖的 RNA 聚合酶（RdRp）的抑制作用：一项分子对接研究。
Life Sci. 2020 Jul 15;253:117592. doi: 10.1016/j.lfs.2020.117592. Epub 2020 Mar 25.
5
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
6
Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors.整合酶抑制剂时代 HIV 阳性个体初始抗逆转录病毒治疗的选择。
PLoS One. 2019 Aug 26;14(8):e0221598. doi: 10.1371/journal.pone.0221598. eCollection 2019.